Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7270)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 19, 2021 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Robinson-Agramonte MA, Gonçalves CA, Noris-García E, Préndes Rivero N, Brigida AL, Schultz S, Siniscalco D, García García RJ. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatr 2021; 11(7): 347-354 [PMID: 34327127 DOI: 10.5498/wjp.v11.i7.347] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i7/347.htm |
| Number | Citing Articles |
| 1 |
Jolanta B. Zawilska, Katarzyna Kuczyńska. Psychiatric and neurological complications of long COVID. Journal of Psychiatric Research 2022; 156: 349 doi: 10.1016/j.jpsychires.2022.10.045
|
| 2 |
Carlos-Alberto Gonçalves, Larissa Daniele Bobermin, Patricia Sesterheim, Carlos Alexandre Netto. SARS-CoV-2-Induced Amyloidgenesis: Not One, but Three Hypotheses for Cerebral COVID-19 Outcomes. Metabolites 2022; 12(11): 1099 doi: 10.3390/metabo12111099
|
| 3 |
A. Fleury, M.A. Del Rio Quiñones, L. Aguirre-Cruz, A. Toledo, I. Murrieta, K. Santiago, E. Uribe, L. Miranda, V. Toledo, W. Soto, D. Sánchez, L. Cruz. Can COVID-19 pandemic worsen previous neurological/psychiatric diseases?. Neurology Perspectives 2022; 2(3): 143 doi: 10.1016/j.neurop.2022.06.002
|
| 4 |
José Wagner Leonel Tavares-Júnior, Gabriella Cunha Vieira Ciurleo, Alissa Moura Formiga, Thais de Maria Frota Vasconcelos, Marcello Holanda de Andrade, Werbety Lucas Queiroz Feitosa, Antônio Alves Sobreira-Neto, Chiara Gübel Portugal, Lorenzo Marinho Morais, Samuel Cavalcante Marinho, Emanuel de Assis Bertulino Martins Gomes, Esther de Alencar Araripe Falcão Feitosa, Emmanuelle Silva Tavares Sobreira, Reinaldo Barreto Oriá, Manoel Alves Sobreira-Neto, Pedro Braga-Neto. Long COVID: neurological manifestations - an updated narrative review. Dementia & Neuropsychologia 2024; 18 doi: 10.1590/1980-5764-dn-2023-0076
|
| 5 |
Rosa Savino, Anna N. Polito, Giulia Arcidiacono, Mariacristina Poliseno, Sergio Lo Caputo. Neuropsychiatric Disorders in Pediatric Long COVID-19: A Case Series. Brain Sciences 2022; 12(5): 514 doi: 10.3390/brainsci12050514
|
| 6 |
Veevarin Charoenporn, Parunkul Tungsukruthai, Thammanard Charernboon, Kusuma Sriyakul, Sophida Sukprasert, Chuntida Kamalashiran. Fatigue and neuropsychiatric manifestations of post-acute sequelae of COVID-19 (PASC): examining the relationship with clinical and inflammatory markers. Fatigue: Biomedicine, Health & Behavior 2024; 12(1): 14 doi: 10.1080/21641846.2023.2286028
|
| 7 |
Nataliia N. Petrova, Victoria M. Manyushina. COVID-19 and the manifestation of psychosis: clinical cases. Neurology Bulletin 2021; (4): 61 doi: 10.17816/nb89686
|
| 8 |
Halwa Zakia, Kent Pradana, Shelly Iskandar, Andrea Martinuzzi. Risk factors for psychiatric symptoms in patients with long COVID: A systematic review. PLOS ONE 2023; 18(4): e0284075 doi: 10.1371/journal.pone.0284075
|
| 9 |
Carlos-Alberto Gonçalves, Patrícia Sesterheim, Krista M. Wartchow, Larissa Daniele Bobermin, Guilhian Leipnitz, André Quincozes-Santos. Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.905218
|
| 10 |
Maria de los Angeles Robinson-Agramonte, Teresa Serrano Sánchez, Elena Noris García, Orlando Rafael Serrano Barrera, Dario Siniscalco. COVID-19 and the Nervous System from a Cuban Experience. Behavioral Sciences 2023; 13(9): 776 doi: 10.3390/bs13090776
|
| 11 |
Stefano Pallanti, Michele Di Ponzio. PANDAS/PANS in the COVID-19 Age: Autoimmunity and Epstein–Barr Virus Reactivation as Trigger Agents?. Children 2023; 10(4): 648 doi: 10.3390/children10040648
|
| 12 |
Miroslava Hristova, Radka Massaldjieava. COGNITIVE IMPAIRMENTS AS A SYMPTOM OF POST-COVID SYNDROME AMONG THE BULGARIAN POPULATION IN THE CONTEXT OF A GLOBAL PANDEMIC: AN ONGOING STUDY. MEDIS – International Journal of Medical Sciences and Research 2023; 2(2): 25 doi: 10.35120/medisij020225h
|
| 13 |
Olivia Mari Matsuo, Livia Lindoso, Heloisa Helena de Sousa Marques, Guilherme V. Polanczyk, Sylvia Costa Lima Farhat, Vera Bain, Thais T. Fink, Fernanda Martins, Camilla Astley, Priscila Suguita, Vitor Trindade, Simone Correa-Silva, Patricia Palmeira, Camila Sanson Yoshino de Paula, Nadia Litvinov, Juliana Caires O.A. Ferreira, Neusa Keico Sakita, Bruno Gualano, Clovis Artur A. Silva, Maria Fernanda Badue Pereira. Mental health among children and adolescents after SARS-CoV-2 infection: A prospective study in a tertiary university hospital. Journal of Infection 2023; 87(6): 576 doi: 10.1016/j.jinf.2023.09.005
|
| 14 |
Olga A. Gus'kova, Elena I. Yaroslavskaya, Boris Y. Prilenskij, Tatyana I. Petelina. ASSOCIATIONS BETWEEN QUALITY OF LIFE WITH PSYCHOLOGICAL STATE, DISORDERS OF THE CARDIOVASCULAR SYSTEM AND PECULIARITIES OF INFECTIOUS PNEUMONIA 3 MONTHS AFTER COVID-19. Complex Issues of Cardiovascular Diseases 2024; 13(1): 16 doi: 10.17802/2306-1278-2024-13-1-16-27
|
| 15 |
Shraddha Sunthwal, Sagar Lad, Preeti Lad. Linking Neuroscience and Behavior in COVID-19. 2024; : 265 doi: 10.1016/B978-0-323-95650-5.00014-8
|
| 16 |
Ana G. Gutiérrez-García, Carlos M. Contreras. Olfactory Epithelium Infection by SARS-CoV-2: Possible Neuroinflammatory Consequences of COVID-19. Complex Psychiatry 2024; 10(1-4): 59 doi: 10.1159/000540982
|
| 17 |
ELENA NORIS-GARCÍA, MARIA DE LOS ANGELES ROBINSON-AGRAMONTE, CARLOS-ALBERTO GONÇALVES. Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic. Archives of Medical Research 2022; 53(5): 543 doi: 10.1016/j.arcmed.2022.05.004
|
| 18 |
Stefano Berloffa, Andrea Salvati, Gloria Pantalone, Ludovica Falcioni, Micaela M. Rizzi, Francesca Naldini, Gabriele Masi, Antonella Gagliano. Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series. Frontiers in Neurology 2023; 14 doi: 10.3389/fneur.2023.1085948
|
| 19 |
Laura López-López, Andrés Calvache-Mateo, Araceli Ortiz-Rubio, María Granados-Santiago, Alejandro Heredia-Ciuró, Javier Martín-Núñez, Marie Carmen Valenza. Differences of Disabling Symptoms between Previously Hospitalized or Non-Hospitalized Currently Working Long-COVID Survivors One Year after Infection: A Descriptive Study. Healthcare 2023; 11(16): 2306 doi: 10.3390/healthcare11162306
|
| 20 |
Margarita A. Mayorova, Leonid P. Churilov, Natalia N. Petrova, Yehuda Shoenfeld. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination. 2023; : 405 doi: 10.1016/B978-0-443-18566-3.00007-4
|
| 21 |
Ting-Bin Chen, Ching-Mao Chang, Cheng-Chia Yang, I-Ju Tsai, Cheng-Yu Wei, Hao-Wen Yang, Chun-Pai Yang. Neuroimmunological Effect of Vitamin D on Neuropsychiatric Long COVID Syndrome: A Review. Nutrients 2023; 15(17): 3802 doi: 10.3390/nu15173802
|
| 22 |
Niloufar Zia, Parsa Ravanfar, Sepideh Allahdadian, Mehdi Ghasemi. Impact of COVID-19 on Neuropsychiatric Disorders. Journal of Clinical Medicine 2022; 11(17): 5213 doi: 10.3390/jcm11175213
|
| 23 |
Erika Plazas, Nicoletta Faraone. Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents. Biomedicines 2023; 11(2): 461 doi: 10.3390/biomedicines11020461
|
| 24 |
Adriana Prato, Angela Maria Salerno, Federica Saia, Nicoletta Maugeri, Alice Zanini, Miriam Scerbo, Rita Barone, Renata Rizzo. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment. BMC Pediatrics 2023; 23(1) doi: 10.1186/s12887-023-04035-9
|